Reading time: 5 minutes · Listening time: 6 minutes. Prefer to listen? Flip reads this week's Brief here.

---

For twenty-five years I have watched carriers buy each other for scale.

The pitch is always the same: a bigger combined book with cost synergies in year two. A stronger negotiating position with reinsurers. I've nodded through that deck more times than I can count.

Most of those deals didn't pay what they promised.

I knew it. The CFOs across the table probably suspected it. Nobody had the numbers.

ACORD ran them this month.

Among the P&C carrier acquisitions in their sample, 40% left shareholders worse off than the MSCI World Index. The buyers spent real money and got less back than if they had done nothing. This week: the returns data, the deal market producing it, and the coverage gap that catches a board even when the deal was a good one.

• Deal count just posted its slowest first half in a decade. The individual checks got much bigger.
• ACORD sorted 34 carrier acquisitions by why the buyer bought. The motive predicted the return.
• A seller's tail policy, a buyer's new one, and the claim that lands in the gap between them.

---

Fewer deals. Bigger checks.

Summary

Insurance M&A just posted its slowest first half since 2016.

OPTIS Partners counted 292 agency and brokerage deals in the first six months of 2026, down 15% from last year, with ten buyers accounting for 45% of them. The individual transactions went the other direction: Corebridge and Equitable agreed to an all-stock merger worth roughly $22 billion, Zurich agreed terms on Beazley at $10.9 billion, and The Doctors Company closed its $1.3 billion purchase of ProAssurance and took a public specialty carrier private.

Two different trends. Both reach your renewal.

So what?

This reaches you even if you never sign a deal.

Two different things are consolidating, and they hit you in different places. Broker roll-ups (the OPTIS count) change who distributes your business. Carrier mergers like Zurich-Beazley reduce the number of insurers competing for your business, narrowing your options and weakening your negotiating position at renewal.

When a carrier on your D&O (directors and officers liability), E&O (errors and omissions), or reinsurance panel gets absorbed, your next renewal can land in a thinner market, a shifted appetite, or a flat non-renewal. None of those are problems you created. All of them are problems you inherit.

This is happening in a D&O market that has been softening for two years. Rate reductions on clean FI accounts are still available at primary and low-excess layers, but the number of carriers willing to write those layers is quietly shrinking. The soft pricing buys time. The consolidation is taking it away.

Ask the question before your next renewal: which incumbent markets and reinsurers would hurt you most if they sold? If you don't have a backup panel identified for those seats, build one now.

EY has indicated it expects additional billion-dollar transactions before year-end.

(sources: Insurance Journal, Business Insurance; Insurance Business Magazine, July 2026)

Want to know which carriers on your panel are the likeliest to be absorbed? Contact LION Specialty and we'll map your program's consolidation exposure before renewal season, so you build the backup panel on your timeline.

---

What 34 carrier deals actually paid shareholders

Summary

ACORD's 2026 study screened roughly 2,800 insurance transactions closed between July 2023 and December 2025.

From those it isolated 34 public carrier deals (disclosed value, unaffiliated parties, publicly traded buyer) and measured total shareholder return against the MSCI World Index. Sixty-eight percent created value. Thirty-two percent destroyed it.

Read it as a strong pattern, not a law.

The LION Lens

What happened — ACORD sorted those 34 deals by the buyer's stated motivation: scale, core expansion, capability acquisition, or diversification.

Why it matters — Motivation tracked closely with result. Deals built on scale returned 13.6% below the index. Deals built on acquiring a capability the buyer could not build internally returned 27.7% above it. Same money. Opposite outcome. The difference was why.

Practical implications — Weight the why as heavily as the price. A capability case with named integration owners has beaten a scale case in this dataset. Price still matters; this is about the reason for the deal, not a license to overpay.

So what?

The scale finding lands hard in a market where scale is the loudest pitch.

ACORD is blunt about why. Cost synergies arrive smaller and slower than projected, or get offset by dis-synergies. Buyers underestimate integration cost and duration while overestimating their own ability to execute. Past a certain size, bureaucratic drag and slower decisions erode the organic growth the deal was supposed to buy.

Diversification is the opposite story. It was the least-used rationale of the previous decade, at 12% of deals, returning -3.4%. In the recent period it jumped to the most common at 41% and beat the index by 13.7%. Life was the sharpest reversal: negative across every rationale for 2013-2023, and the best-performing segment since at +23.4%. Our read, not ACORD's: a good part of that turnaround looks like a private-equity and offshore-reinsurance capital story rather than underwriting skill, and I would want to see it through a full credit cycle before calling it durable.

What separated the winners from the losers was execution. ACORD's impediment list is unglamorous: culture clashes, core systems that don't talk to each other, key people who leave, governance that nobody clarified before closing. The deal thesis can be right and still die in the integration.

The LION POV

How we are advising clients on this:

• Underwrite the motive before the multiple. Ask what the deal buys that you cannot build internally. If the honest answer is size, the data in this sample says your shareholders tend to pay for it.
• Price the integration, then double it. ACORD found buyers routinely underpriced integration cost and duration. Add cyber and model-risk diligence to the same screen. A stale security posture transfers to your balance sheet on closing day.
• Insure the transaction like the risk it is. Deal-stage D&O wording, tail coverage, and reps-and-warranties terms (the contractual warranties between buyer and seller that allocate risk at closing) get set once, before the deal closes. Revisiting them afterward is either impossible or prohibitively expensive.
• Check your disclosures. Boards evaluating a scale-driven transaction should consider whether their proxy materials are consistent with the risk environment ACORD describes.

Fewer deals with bigger stakes puts more scrutiny on each one, from investors, regulators, and plaintiffs. Litigation funding continues to increase the frequency and severity of securities class actions, and that pressure reaches your D&O renewal whether or not you ever sign a deal.

Have a transaction anywhere on the board's agenda this year? Contact LION Specialty for a confidential read on your deal-stage D&O and tail wording while those terms are still negotiable.

(source: ACORD, Carrier Mergers & Acquisitions 2026)

---

The claim that arrives too early and too late

Summary

Two D&O policies. Two premiums. One real argument about whether either one responds.

Reed Smith's Courtney Horrigan, Russell Squire, and Kathleen Murphy named it in Law360 in February: a straddle claim, an allegation of wrongdoing that spans both sides of a closing date. It falls in the gap between the seller's tail policy and the buyer's go-forward policy — too late to sit cleanly in one, too early for the other.

The policyholder ends up, in their words, "caught between two denial letters."

So what?

The piece includes a case from their own practice that makes the problem concrete.

In one spin-off, the parties negotiated a tail endorsement that defined straddle claims up front. Two straddle claims arrived later. Nobody litigated coverage. In a different deal without one, both carriers denied. The policyholder spent its own money fighting two exclusions at once.

Most of you aren't selling the institution this quarter. The same seam opens at an ordinary renewal.

When an organization changes its D&O carrier, the new policy sets a prior-acts date, the cut-off before which claims arising from past conduct may not be covered. A community bank that switches carriers inherits a new one, and that date decides whether last year's conduct is still protected. The same gap sits on a cyber tower when an intrusion starts before the switch and surfaces after. For carrier buyers, the professional liability tail creates an even more complex version of the same seam: E&O and ICPL (insurer's professional liability) exposure from the acquired book's claims handling.

Three things decide it.

1. The prior-acts date.
2. The definition that folds related allegations into a single claim.
3. How two towers share a loss when both are arguably covering it.

Get them in writing before you sign.

(source: Law360, "Mind The Gap: Crafting D&O Straddle Coverage For M&A," Feb. 20, 2026)

---

Next Wednesday we take this from the law review to the deal room. The Wednesday Intelligence deep dive walks the three wording moves that close the straddle gap: what to push for in the tail's trigger language, how to map the seam between your two policies before signing, and the endorsement that made the difference in that spin-off. We will also address the E&O/ICPL tail seam for carrier-on-carrier transactions. If a transaction is anywhere on your board's agenda, that edition is your pre-closing checklist.

---

The Bottom Line

The three run together.

The deal market narrowed to fewer, bigger bets and thinned the panel you renew into. The deals that destroyed value mostly failed on execution, not strategy. And even a good deal, or a routine carrier switch, can strand a board in the seam between two policies that were both supposed to be paying.

The boards that come out ahead treat the deal, the integration, and the insurance as one decision. Not three.

LION has published a structured review of the five most common D&O program gaps: the D&O Contract Vigilance Blueprint, a five-day email course available to clients and subscribers preparing for renewal.

• The policy mistakes we see most often when reviewing D&O programs
• Where your personal assets sit when the company can't indemnify you

Want it? Just reply to this email with the word "blueprint" and I'll sign you up.

Thank you for reading today's edition.

Stay Covered Everybody,

-FLIP

P.S. Want to share this edition? Copy the link below:

https://lionspecialty.kit.com/posts/m-a-s-slowest-first-half-since-2016-40-of-p-c-deals-trailed-the-index-the-d-o-claim-caught-between-two-policies

And if this was forwarded to you, subscribe here: https://lionspecialty.kit.com/. Next Wednesday: the deal-room playbook for straddle claims, D&O and E&O/ICPL, worth reading before your next letter of intent.

P.P.S. Nothing here is legal advice or a recommendation to take or refrain from any specific action. It is market intelligence to help you ask sharper questions at renewal.

---

You're receiving this because you subscribed to the LION Specialty Boardroom Brief.
Unsubscribe  ·  Update your preferences